Seoul Pharma Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seoul Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 1 930 KRW -0.16%

Market Cap: ₩22.5B

S	Seoul Pharma Co Ltd KOSDAQ:018680	KR
	Megalestari Epack Sentosaraya Tbk PT IDX:EPAC	ID
	Braskem SA BOVESPA:BRKM5	BR
C	Canamera Energy Metals Corp CNSX:EMET	CA
	Deutsche Pfandbriefbank AG OTC:PBBGF	DE
	Supply Network Ltd ASX:SNL	AU
M	MOL Magyar Olajes Gazipari Nyrt WSE:MOL	HU

Profitability Summary

Seoul Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

62% > 59%

Negative Operating Margin

-2%

Low 3Y Average Operating Margin

Declining Operating Margin

3% > -2%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

7% > 3%

Exceptional Free Cash Flow Margin

17%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.